A Multicenter, Prospective, Cohort Study to Evaluate the Efficacy and Safety of Fixed-Dose Combination of Pitavastatin/Ezetimibe Under the Real-World Condition
Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY
The purpose of this study is to evaluate the efficacy and safety of fixed-Dose combination of Pitavastatin/Ezetimibe under the real-world condition
Eligibility
Participation Requirements
Sex: All
Minimum Age: 19
Healthy Volunteers: f
View:
• Those who taking statins or statins and ezetimibe in addition to dietary and exercise therapy for primary hypercholesterolemia or mixed hyperlipidemia
• Those who are judged to need administration of a fixed-dose combination of pitavastatin/ezetimibe for change of statin's formulation or change of statin's dose, addition of ezetimibe
Locations
Other Locations
Republic of Korea
Ewha Womans University Seoul Hospital
RECRUITING
Seoul
Contact Information
Primary
Shin-young Oh
syoh@boryung.co.kr
+82-2-708-8000
Time Frame
Start Date: 2024-03-15
Estimated Completion Date: 2026-06
Participants
Target number of participants: 8606
Related Therapeutic Areas
Sponsors
Leads: Boryung Pharmaceutical Co., Ltd